US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Theriva Biologics

0.2369

+0.00190.81%

Volume:265.25K

Turnover:62.86K

Market Cap:10.87M

PE:-0.34

High:0.2419

Open:0.2364

Low:0.2330

Close:0.2350

52wk High:0.8632

52wk Low:0.1628

Shares:45.89M

Float Shares:45.14M

Volume Ratio:0.89

T/O Rate:0.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6904

EPS(LYR):-2.0797

ROE:-101.87%

ROA:-21.34%

PB:0.89

PE(LYR):-0.11

Loading ...

Overview Company News Filings

Theriva Biologics Q1 EPS $(0.05), Inline

Benzinga Earnings

Press Release: Theriva(TM) Biologics Reports First Quarter 2026 Operational Highlights and Financial Results

Top Premarket Gainers

MT Newswires Live

Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial

Theriva to present new VIRAGE Phase 2b VCN-01 data in metastatic pancreatic cancer at AACR

Theriva™ Biologics Announces Upcoming Presentation of Additional Data From the Virage Phase 2B Clinical Trial of Vcn-01 in Metastatic Pancreatic Cancer at Aacr 2026 Annual Meeting

THOMSON REUTERS

Theriva Biologics Faces Delays in Warrant Approval Meeting

Theriva Biologics Raised to Buy From Hold by Maxim Group

Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path

Analysts Have Conflicting Sentiments on These Healthcare Companies: Apogee Therapeutics (APGE) and Theriva Biologics (TOVX)

Theriva Biologics Advances VCN-01 Into Pivotal Phase 3

Theriva Biologics reports FDA agreement on Phase 3 VCN-01 trial design in metastatic pancreatic cancer

Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting With U.S. FDA Regarding the Design of a Phase 3 Trial of Vcn-01 in Metastatic Pancreatic Ductal Adenocarcinoma

THOMSON REUTERS

Theriva Biologics price target lowered to $4 from $7 at Alliance Global

Theriva Biologics Q4 EPS $(0.12) Beats $(0.50) Estimate

Benzinga Earnings

Press Release: Theriva(TM) Biologics Reports Full-Year 2025 Operational Highlights and Financial Results

Theriva Biologics FY2025 net loss attributable to common stockholders was USD 25.25 million and G&A expenses more than doubled to USD 15.45 million

Theriva Biologics Inc: Anticipates Research & Development Expense to Decrease in 2026

THOMSON REUTERS

Alliance Global Partners Sticks to Its Buy Rating for Theriva Biologics (TOVX)

BRIEF-Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TOVX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TOVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","market":"US","secType":"STK","nameCN":"Theriva Biologics","latestPrice":0.2369,"timestamp":1787590793714,"preClose":0.235,"halted":0,"volume":265251,"delay":0,"changeRate":0.008085106382978779,"floatShares":45143400,"shares":45892668,"eps":-0.6904,"marketStatus":"Trading","change":0.0019,"latestTime":"08-24 13:00:55 EDT","open":0.2364,"high":0.2419,"low":0.233,"amount":62864.821216259996,"amplitude":0.037872,"askPrice":0.2574,"askSize":1900,"bidPrice":0.2243,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.6904,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":0.235,"preHourTrading":{"tag":"盘前","latestPrice":0.2398,"preClose":0.235,"latestTime":"09:21 EDT","volume":21453,"amount":5118.9368001,"timestamp":1787577660466,"change":0.0048,"changeRate":0.020426,"amplitude":0.039574},"postHourTrading":{"tag":"盘后","latestPrice":0.2312,"preClose":0.235,"latestTime":"19:48 EDT","volume":10339,"amount":2452.5739,"timestamp":1787356104620,"change":-0.0038,"changeRate":-0.01617,"amplitude":0.036596},"volumeRatio":0.887441},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","floatShares":45143400,"roa":"-21.34%","roe":"-101.87%","lyrEps":-2.079699,"volumeRatio":0.887441,"shares":45892668,"dividePrice":0,"high":0.2419,"amplitude":0.037872,"preClose":0.235,"low":0.233,"week52Low":0.1628,"pbRate":"0.89","psRate":"36.24","week52High":0.8632,"institutionHeld":0.0983,"latestPrice":0.2369,"committee":-0.9,"eps":-0.6904,"divideRate":0,"volume":265251,"delay":0,"ttmEps":-0.6904,"open":0.2364,"prevYearClose":0.2104,"prevWeekClose":0.235,"prevMonthClose":0.21,"prevQuarterClose":0.2502,"fiveDayClose":0.2376,"twentyDayClose":0.213,"sixtyDayClose":0.309},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TOVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"TOVX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2026-05-05","symbol":"TOVX","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-0.05},{"date":"2026-03-12","symbol":"TOVX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1773302400000,"name":null,"time":"Pre-MKt","dateTimestamp":1773288000000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"TOVX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"TOVX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.93}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TOVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TOVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775016000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TOVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TOVX","date":"2026-08-21","current":-0.340382,"percent":0.235102,"low":-6.845814,"twenty":-1.363639,"median":-0.448751,"eighty":-0.161746,"high":-0.056131,"avg":-1.032044,"sd":1.461085,"marketCap":10564492},"quantilePoints":[{"date":"2021-08-27","current":-6.452727,"twenty":-3.130706,"median":-0.729547,"eighty":-0.542403,"marketCap":64159465},{"date":"2021-09-03","current":-6.726294,"twenty":-3.178396,"median":-0.729686,"eighty":-0.542403,"marketCap":66879541},{"date":"2021-09-10","current":-6.798006,"twenty":-3.194253,"median":-0.732303,"eighty":-0.542403,"marketCap":67592571},{"date":"2021-09-17","current":-6.382343,"twenty":-3.213982,"median":-0.741153,"eighty":-0.542537,"marketCap":63459639},{"date":"2021-09-24","current":-6.566935,"twenty":-3.278986,"median":-0.742349,"eighty":-0.54297,"marketCap":65295031},{"date":"2021-10-01","current":-6.030425,"twenty":-3.304661,"median":-0.747481,"eighty":-0.543109,"marketCap":59960512},{"date":"2021-10-08","current":-5.617418,"twenty":-3.334322,"median":-0.752374,"eighty":-0.543701,"marketCap":55853990},{"date":"2021-10-15","current":-5.772794,"twenty":-3.345181,"median":-0.752851,"eighty":-0.544169,"marketCap":57398887},{"date":"2021-10-22","current":-5.391659,"twenty":-3.400752,"median":-0.754125,"eighty":-0.544316,"marketCap":53609267},{"date":"2021-10-29","current":-5.492587,"twenty":-3.745956,"median":-0.764317,"eighty":-0.544913,"marketCap":54612790},{"date":"2021-11-05","current":-4.992736,"twenty":-4.551182,"median":-0.764433,"eighty":-0.545058,"marketCap":55484271},{"date":"2021-11-12","current":-4.65054,"twenty":-4.730623,"median":-0.768317,"eighty":-0.546509,"marketCap":51681446},{"date":"2021-11-19","current":-4.277451,"twenty":-4.687373,"median":-0.770925,"eighty":-0.546872,"marketCap":47535310},{"date":"2021-11-26","current":-4.063578,"twenty":-4.671179,"median":-0.774385,"eighty":-0.547752,"marketCap":45158545},{"date":"2021-12-03","current":-3.680984,"twenty":-4.657329,"median":-0.786323,"eighty":-0.548571,"marketCap":40906775},{"date":"2021-12-10","current":-3.868717,"twenty":-4.641812,"median":-0.787309,"eighty":-0.548963,"marketCap":42993047},{"date":"2021-12-17","current":-3.847329,"twenty":-4.627611,"median":-0.788987,"eighty":-0.549663,"marketCap":42755371},{"date":"2021-12-23","current":-3.938225,"twenty":-4.585205,"median":-0.79918,"eighty":-0.550108,"marketCap":43765496},{"date":"2021-12-31","current":-3.234228,"twenty":-4.516893,"median":-0.803705,"eighty":-0.55026,"marketCap":35941976},{"date":"2022-01-07","current":-3.301954,"twenty":-4.470466,"median":-0.810762,"eighty":-0.551195,"marketCap":36694619},{"date":"2022-01-14","current":-3.132044,"twenty":-4.416951,"median":-0.818396,"eighty":-0.552757,"marketCap":34806410},{"date":"2022-01-21","current":-2.977581,"twenty":-4.382338,"median":-0.823792,"eighty":-0.553146,"marketCap":33089858},{"date":"2022-01-28","current":-2.756579,"twenty":-4.314522,"median":-0.839718,"eighty":-0.55352,"marketCap":30633866},{"date":"2022-02-04","current":-2.817177,"twenty":-4.277451,"median":-0.860023,"eighty":-0.554015,"marketCap":31307283},{"date":"2022-02-11","current":-3.114222,"twenty":-4.269229,"median":-0.879323,"eighty":-0.554319,"marketCap":34608347},{"date":"2022-02-18","current":-3.003721,"twenty":-4.232683,"median":-0.896124,"eighty":-0.554405,"marketCap":33380351},{"date":"2022-02-25","current":-2.82787,"twenty":-4.218042,"median":-0.920532,"eighty":-0.554406,"marketCap":31426122},{"date":"2022-03-04","current":-2.881338,"twenty":-4.112294,"median":-0.956767,"eighty":-0.555309,"marketCap":32020313},{"date":"2022-03-11","current":-2.825494,"twenty":-4.099224,"median":-1.006209,"eighty":-0.555502,"marketCap":31399713},{"date":"2022-03-18","current":-4.775235,"twenty":-4.099224,"median":-1.037737,"eighty":-0.556101,"marketCap":68128271},{"date":"2022-03-25","current":-3.919024,"twenty":-4.099224,"median":-1.064779,"eighty":-0.556465,"marketCap":55912713},{"date":"2022-04-01","current":-3.194965,"twenty":-4.099224,"median":-1.08458,"eighty":-0.556893,"marketCap":45582566},{"date":"2022-04-08","current":-2.887351,"twenty":-4.063578,"median":-1.094696,"eighty":-0.558899,"marketCap":41193838},{"date":"2022-04-14","current":-2.942877,"twenty":-4.016051,"median":-1.111061,"eighty":-0.559105,"marketCap":41986027},{"date":"2022-04-22","current":-2.709668,"twenty":-3.997515,"median":-1.129172,"eighty":-0.559519,"marketCap":38658832},{"date":"2022-04-29","current":-2.653031,"twenty":-3.983495,"median":-1.139179,"eighty":-0.560037,"marketCap":37850799},{"date":"2022-05-06","current":-2.724105,"twenty":-3.949038,"median":-1.14331,"eighty":-0.560197,"marketCap":38864802},{"date":"2022-05-13","current":-2.54309,"twenty":-3.938819,"median":-1.151205,"eighty":-0.560273,"marketCap":36282265},{"date":"2022-05-20","current":-2.161146,"twenty":-3.926343,"median":-1.156529,"eighty":-0.56058,"marketCap":34586980},{"date":"2022-05-27","current":-2.159166,"twenty":-3.919894,"median":-1.156897,"eighty":-0.561617,"marketCap":34555292},{"date":"2022-06-03","current":-2.133426,"twenty":-3.909696,"median":-1.165802,"eighty":-0.56225,"marketCap":34143354},{"date":"2022-06-10","current":-2.078977,"twenty":-3.896879,"median":-1.16828,"eighty":-0.56264,"marketCap":33271946},{"date":"2022-06-17","current":-1.864149,"twenty":-3.879648,"median":-1.175074,"eighty":-0.563105,"marketCap":29833845},{"date":"2022-06-24","current":-1.918599,"twenty":-3.870143,"median":-1.182994,"eighty":-0.563591,"marketCap":30705253},{"date":"2022-07-01","current":-2.276975,"twenty":-3.861743,"median":-1.193251,"eighty":-0.564291,"marketCap":36440703},{"date":"2022-07-08","current":-2.351224,"twenty":-3.850491,"median":-1.193434,"eighty":-0.56495,"marketCap":37628987},{"date":"2022-07-15","current":-1.613682,"twenty":-3.844122,"median":-1.200778,"eighty":-0.565523,"marketCap":25825367},{"date":"2022-07-22","current":-1.534483,"twenty":-3.830182,"median":-1.211611,"eighty":-0.565679,"marketCap":24557865},{"date":"2022-07-29","current":-1.425584,"twenty":-3.824355,"median":-1.222168,"eighty":-0.565726,"marketCap":22815048},{"date":"2022-08-05","current":-1.435484,"twenty":-3.815486,"median":-1.229972,"eighty":-0.566106,"marketCap":22973486},{"date":"2022-08-12","current":-1.310163,"twenty":-3.80099,"median":-1.231807,"eighty":-0.567168,"marketCap":23290769},{"date":"2022-08-19","current":-1.336901,"twenty":-3.796,"median":-1.248516,"eighty":-0.56839,"marketCap":23766091},{"date":"2022-08-26","current":-1.354726,"twenty":-3.791193,"median":-1.256699,"eighty":-0.568728,"marketCap":24082972},{"date":"2022-09-02","current":-1.283425,"twenty":-3.766883,"median":-1.265958,"eighty":-0.568978,"marketCap":22815447},{"date":"2022-09-09","current":-1.274512,"twenty":-3.731346,"median":-1.2656,"eighty":-0.569201,"marketCap":22657007},{"date":"2022-09-16","current":-1.194298,"twenty":-3.702371,"median":-1.258398,"eighty":-0.569382,"marketCap":21231041},{"date":"2022-09-23","current":-0.944743,"twenty":-3.68336,"median":-1.248516,"eighty":-0.571834,"marketCap":16794704},{"date":"2022-09-30","current":-0.87879,"twenty":-3.680984,"median":-1.247774,"eighty":-0.572488,"marketCap":15622244},{"date":"2022-10-07","current":-0.944743,"twenty":-3.623359,"median":-1.238862,"eighty":-0.572707,"marketCap":16794704},{"date":"2022-10-14","current":-0.882444,"twenty":-3.598084,"median":-1.230155,"eighty":-0.573146,"marketCap":15687204},{"date":"2022-10-21","current":-0.819966,"twenty":-3.578801,"median":-1.229949,"eighty":-0.574242,"marketCap":14576536},{"date":"2022-10-28","current":-0.677363,"twenty":-3.562166,"median":-1.222168,"eighty":-0.575776,"marketCap":12041486},{"date":"2022-11-04","current":-0.643941,"twenty":-3.550284,"median":-1.211611,"eighty":-0.57763,"marketCap":11447334},{"date":"2022-11-11","current":-0.504821,"twenty":-3.533232,"median":-1.20188,"eighty":-0.575776,"marketCap":9771824},{"date":"2022-11-18","current":-0.572963,"twenty":-3.505133,"median":-1.198208,"eighty":-0.572707,"marketCap":11090842},{"date":"2022-11-25","current":-0.570917,"twenty":-3.42425,"median":-1.193434,"eighty":-0.571651,"marketCap":11051232},{"date":"2022-12-02","current":-0.589333,"twenty":-3.403021,"median":-1.191874,"eighty":-0.572357,"marketCap":11407723},{"date":"2022-12-09","current":-0.487591,"twenty":-3.400752,"median":-1.177694,"eighty":-0.569346,"marketCap":9438307},{"date":"2022-12-16","current":-0.459925,"twenty":-3.391351,"median":-1.174155,"eighty":-0.56803,"marketCap":8902777},{"date":"2022-12-23","current":-0.328234,"twenty":-3.388948,"median":-1.165893,"eighty":-0.56564,"marketCap":6353618},{"date":"2022-12-30","current":-0.355345,"twenty":-3.385925,"median":-1.16571,"eighty":-0.563708,"marketCap":6878422},{"date":"2023-01-06","current":-0.453167,"twenty":-3.379661,"median":-1.156529,"eighty":-0.561376,"marketCap":8771955},{"date":"2023-01-13","current":-0.531221,"twenty":-3.359732,"median":-1.147716,"eighty":-0.55993,"marketCap":10282849},{"date":"2023-01-20","current":-0.59693,"twenty":-3.359732,"median":-1.138353,"eighty":-0.55993,"marketCap":11554782},{"date":"2023-01-27","current":-0.707096,"twenty":-3.331421,"median":-1.101632,"eighty":-0.55993,"marketCap":13687260},{"date":"2023-02-03","current":-0.836015,"twenty":-3.315024,"median":-1.078434,"eighty":-0.55993,"marketCap":16182745},{"date":"2023-02-10","current":-0.812575,"twenty":-3.315024,"median":-1.037737,"eighty":-0.55993,"marketCap":15729023},{"date":"2023-02-17","current":-0.764758,"twenty":-3.315024,"median":-1.016045,"eighty":-0.55993,"marketCap":14803430},{"date":"2023-02-24","current":-0.735225,"twenty":-3.315024,"median":-0.956767,"eighty":-0.55993,"marketCap":14231741},{"date":"2023-03-03","current":-0.673813,"twenty":-3.305797,"median":-0.938905,"eighty":-0.55993,"marketCap":13042990},{"date":"2023-03-10","current":-0.578179,"twenty":-3.302932,"median":-0.918451,"eighty":-0.55993,"marketCap":11191820},{"date":"2023-03-17","current":-0.593805,"twenty":-3.289122,"median":-0.901567,"eighty":-0.55993,"marketCap":11494286},{"date":"2023-03-24","current":-0.483561,"twenty":-3.289122,"median":-0.880893,"eighty":-0.55886,"marketCap":9360281},{"date":"2023-03-31","current":-0.536583,"twenty":-3.284844,"median":-0.860364,"eighty":-0.555981,"marketCap":10562644},{"date":"2023-04-06","current":-0.537736,"twenty":-3.284844,"median":-0.849689,"eighty":-0.554406,"marketCap":10585330},{"date":"2023-04-14","current":-0.545496,"twenty":-3.289122,"median":-0.836015,"eighty":-0.553272,"marketCap":10738083},{"date":"2023-04-21","current":-0.545496,"twenty":-3.289122,"median":-0.822344,"eighty":-0.552002,"marketCap":10738083},{"date":"2023-04-28","current":-0.50831,"twenty":-3.289122,"median":-0.816188,"eighty":-0.548963,"marketCap":10006078},{"date":"2023-05-05","current":-0.560862,"twenty":-3.289122,"median":-0.805845,"eighty":-0.546872,"marketCap":11040564},{"date":"2023-05-12","current":-0.529208,"twenty":-3.289122,"median":-0.789136,"eighty":-0.546322,"marketCap":10417453},{"date":"2023-05-19","current":-0.539873,"twenty":-3.289122,"median":-0.786548,"eighty":-0.545058,"marketCap":10738083},{"date":"2023-05-26","current":-0.504896,"twenty":-3.289122,"median":-0.771626,"eighty":-0.543556,"marketCap":10042376},{"date":"2023-06-02","current":-0.485962,"twenty":-3.293399,"median":-0.76666,"eighty":-0.54247,"marketCap":9665787},{"date":"2023-06-08","current":-0.533866,"twenty":-3.297677,"median":-0.764433,"eighty":-0.542403,"marketCap":10618603},{"date":"2023-06-16","current":-0.53227,"twenty":-3.301954,"median":-0.758263,"eighty":-0.540326,"marketCap":10586842},{"date":"2023-06-23","current":-0.502158,"twenty":-3.303142,"median":-0.752851,"eighty":-0.538322,"marketCap":9987929},{"date":"2023-06-30","current":-0.699554,"twenty":-3.30433,"median":-0.747625,"eighty":-0.537275,"marketCap":13914136},{"date":"2023-07-07","current":-0.623592,"twenty":-3.30433,"median":-0.742349,"eighty":-0.537275,"marketCap":12403242},{"date":"2023-07-14","current":-0.553941,"twenty":-3.30433,"median":-0.735004,"eighty":-0.537275,"marketCap":11017878},{"date":"2023-07-21","current":-0.539113,"twenty":-3.30433,"median":-0.729628,"eighty":-0.536494,"marketCap":10722959},{"date":"2023-07-28","current":-0.481324,"twenty":-3.30433,"median":-0.724498,"eighty":-0.534659,"marketCap":9573530},{"date":"2023-08-04","current":-0.49425,"twenty":-3.30433,"median":-0.720134,"eighty":-0.53286,"marketCap":9830639},{"date":"2023-08-11","current":-0.53295,"twenty":-3.30433,"median":-0.717872,"eighty":-0.53227,"marketCap":10924412},{"date":"2023-08-18","current":-0.440744,"twenty":-3.30433,"median":-0.716071,"eighty":-0.531268,"marketCap":9034369},{"date":"2023-08-25","current":-0.436504,"twenty":-3.30433,"median":-0.714981,"eighty":-0.528148,"marketCap":8947451},{"date":"2023-09-01","current":-0.436504,"twenty":-3.30433,"median":-0.711312,"eighty":-0.523809,"marketCap":8947451},{"date":"2023-09-08","current":-0.422369,"twenty":-3.30433,"median":-0.709081,"eighty":-0.522306,"marketCap":8657724},{"date":"2023-09-15","current":-0.447479,"twenty":-3.30433,"median":-0.709081,"eighty":-0.517062,"marketCap":9172416},{"date":"2023-09-22","current":-0.430517,"twenty":-3.30433,"median":-0.709081,"eighty":-0.514706,"marketCap":8824743},{"date":"2023-09-29","current":-0.415801,"twenty":-3.305519,"median":-0.711004,"eighty":-0.51278,"marketCap":8523086},{"date":"2023-10-06","current":-0.407403,"twenty":-3.305519,"median":-0.705538,"eighty":-0.509488,"marketCap":8350954},{"date":"2023-10-13","current":-0.394932,"twenty":-3.305519,"median":-0.70319,"eighty":-0.508104,"marketCap":8095313},{"date":"2023-10-20","current":-0.374146,"twenty":-3.305519,"median":-0.70319,"eighty":-0.507081,"marketCap":7669244},{"date":"2023-10-27","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.505133,"marketCap":7669244},{"date":"2023-11-03","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.503666,"marketCap":7669244},{"date":"2023-11-10","current":-0.374146,"twenty":-3.31146,"median":-0.70319,"eighty":-0.501843,"marketCap":7669244},{"date":"2023-11-17","current":-0.351002,"twenty":-3.31146,"median":-0.697375,"eighty":-0.499296,"marketCap":6650086},{"date":"2023-11-24","current":-0.474857,"twenty":-3.31146,"median":-0.691269,"eighty":-0.497519,"marketCap":9169007},{"date":"2023-12-01","current":-0.528697,"twenty":-3.31146,"median":-0.684846,"eighty":-0.496211,"marketCap":10208616},{"date":"2023-12-08","current":-0.52958,"twenty":-3.307895,"median":-0.679746,"eighty":-0.496235,"marketCap":10225659},{"date":"2023-12-15","current":-0.518547,"twenty":-3.307895,"median":-0.675604,"eighty":-0.494662,"marketCap":10012624},{"date":"2023-12-22","current":-0.450143,"twenty":-3.307895,"median":-0.673813,"eighty":-0.494275,"marketCap":8691810},{"date":"2023-12-29","current":-0.390036,"twenty":-3.31146,"median":-0.671761,"eighty":-0.494091,"marketCap":7531197},{"date":"2024-01-05","current":-0.394272,"twenty":-3.315024,"median":-0.66912,"eighty":-0.493262,"marketCap":7613003},{"date":"2024-01-12","current":-0.370794,"twenty":-3.315024,"median":-0.668011,"eighty":-0.491925,"marketCap":7159665},{"date":"2024-01-19","current":-0.366293,"twenty":-3.318589,"median":-0.667779,"eighty":-0.490835,"marketCap":7072747},{"date":"2024-01-26","current":-0.372824,"twenty":-3.315024,"median":-0.664015,"eighty":-0.4874,"marketCap":7198863},{"date":"2024-02-02","current":-0.455086,"twenty":-3.315024,"median":-0.660462,"eighty":-0.48591,"marketCap":8787249},{"date":"2024-02-09","current":-0.472562,"twenty":-3.315024,"median":-0.658221,"eighty":-0.484311,"marketCap":9124696},{"date":"2024-02-16","current":-0.41572,"twenty":-3.315024,"median":-0.656727,"eighty":-0.483435,"marketCap":8027142},{"date":"2024-02-23","current":-0.433285,"twenty":-3.315024,"median":-0.655171,"eighty":-0.482634,"marketCap":8366293},{"date":"2024-03-01","current":-0.410424,"twenty":-3.31146,"median":-0.652353,"eighty":-0.480846,"marketCap":7924885},{"date":"2024-03-08","current":-0.406011,"twenty":-3.31146,"median":-0.649964,"eighty":-0.476369,"marketCap":7839671},{"date":"2024-03-15","current":-0.364616,"twenty":-3.31146,"median":-0.648423,"eighty":-0.474686,"marketCap":7040366},{"date":"2024-03-22","current":-0.443876,"twenty":-3.31146,"median":-0.645425,"eighty":-0.47327,"marketCap":8570806},{"date":"2024-03-28","current":-0.452789,"twenty":-3.31146,"median":-0.644454,"eighty":-0.471532,"marketCap":8308229},{"date":"2024-04-05","current":-0.401856,"twenty":-3.315024,"median":-0.641005,"eighty":-0.468806,"marketCap":7373661},{"date":"2024-04-12","current":-0.411202,"twenty":-3.315024,"median":-0.63863,"eighty":-0.465918,"marketCap":7545141},{"date":"2024-04-19","current":-0.418678,"twenty":-3.315024,"median":-0.636957,"eighty":-0.462258,"marketCap":7682325},{"date":"2024-04-26","current":-0.383119,"twenty":-3.31146,"median":-0.634914,"eighty":-0.458969,"marketCap":7029842},{"date":"2024-05-03","current":-0.390642,"twenty":-3.31146,"median":-0.632448,"eighty":-0.457367,"marketCap":7167884},{"date":"2024-05-10","current":-0.363932,"twenty":-3.31146,"median":-0.631649,"eighty":-0.455239,"marketCap":6927811},{"date":"2024-05-17","current":-0.336907,"twenty":-3.31146,"median":-0.627161,"eighty":-0.452468,"marketCap":6413370},{"date":"2024-05-24","current":-0.300421,"twenty":-3.31146,"median":-0.62339,"eighty":-0.450143,"marketCap":5718809},{"date":"2024-05-31","current":-0.242606,"twenty":-3.31146,"median":-0.62339,"eighty":-0.449152,"marketCap":4618241},{"date":"2024-06-07","current":-0.242787,"twenty":-3.31146,"median":-0.62339,"eighty":-0.446856,"marketCap":4621696},{"date":"2024-06-14","current":-0.218735,"twenty":-3.315024,"median":-0.623592,"eighty":-0.443857,"marketCap":4163846},{"date":"2024-06-21","current":-0.222547,"twenty":-3.318589,"median":-0.62339,"eighty":-0.441359,"marketCap":4236411},{"date":"2024-06-28","current":-0.220641,"twenty":-3.32857,"median":-0.625058,"eighty":-0.440638,"marketCap":4200128},{"date":"2024-07-05","current":-0.208752,"twenty":-3.32857,"median":-0.619265,"eighty":-0.43957,"marketCap":3973795},{"date":"2024-07-12","current":-0.23598,"twenty":-3.32857,"median":-0.616695,"eighty":-0.436682,"marketCap":4492116},{"date":"2024-07-15","current":-0.23598,"twenty":-3.32857,"median":-0.615556,"eighty":-0.436504,"marketCap":4492116},{"date":"2024-08-02","current":-0.198042,"twenty":-3.380136,"median":-0.617262,"eighty":-0.435015,"marketCap":3769922},{"date":"2024-08-09","current":-0.190599,"twenty":-3.380136,"median":-0.617262,"eighty":-0.432566,"marketCap":3628247},{"date":"2024-08-16","current":-0.154796,"twenty":-3.380136,"median":-0.617262,"eighty":-0.431604,"marketCap":3446835},{"date":"2024-08-23","current":-0.146835,"twenty":-3.380136,"median":-0.617262,"eighty":-0.430459,"marketCap":3269573},{"date":"2024-08-30","current":-0.212183,"twenty":-3.380136,"median":-0.617262,"eighty":-0.428972,"marketCap":4724670},{"date":"2024-09-06","current":-0.145368,"twenty":-3.380136,"median":-0.617262,"eighty":-0.427851,"marketCap":3236901},{"date":"2024-09-13","current":-0.162523,"twenty":-3.380136,"median":-0.617262,"eighty":-0.424552,"marketCap":3618896},{"date":"2024-09-20","current":-0.1711,"twenty":-3.380136,"median":-0.610449,"eighty":-0.423664,"marketCap":3809893},{"date":"2024-09-27","current":-0.124035,"twenty":-3.380136,"median":-0.610449,"eighty":-0.420134,"marketCap":2761878},{"date":"2024-10-04","current":-0.108834,"twenty":-3.380136,"median":-0.610449,"eighty":-0.418838,"marketCap":2423412},{"date":"2024-10-11","current":-0.159206,"twenty":-3.380136,"median":-0.610449,"eighty":-0.416624,"marketCap":3545040},{"date":"2024-10-18","current":-0.14798,"twenty":-3.380136,"median":-0.610449,"eighty":-0.415718,"marketCap":3295069},{"date":"2024-10-25","current":-0.153083,"twenty":-3.380136,"median":-0.610449,"eighty":-0.413435,"marketCap":3408693},{"date":"2024-10-31","current":-0.151042,"twenty":-3.380136,"median":-0.610449,"eighty":-0.411202,"marketCap":3363243},{"date":"2024-11-08","current":-0.220439,"twenty":-3.380374,"median":-0.611466,"eighty":-0.40952,"marketCap":4908517},{"date":"2024-11-15","current":-0.114938,"twenty":-3.380374,"median":-0.611466,"eighty":-0.407403,"marketCap":3067823},{"date":"2024-11-22","current":-0.125524,"twenty":-3.380374,"median":-0.611466,"eighty":-0.406011,"marketCap":3350351},{"date":"2024-11-29","current":-0.150115,"twenty":-3.380374,"median":-0.611466,"eighty":-0.405129,"marketCap":4006726},{"date":"2024-12-06","current":-0.134478,"twenty":-3.380374,"median":-0.611466,"eighty":-0.401856,"marketCap":3589359},{"date":"2024-12-13","current":-0.124054,"twenty":-3.380374,"median":-0.611466,"eighty":-0.398663,"marketCap":3311114},{"date":"2024-12-20","current":-0.119884,"twenty":-3.380374,"median":-0.611466,"eighty":-0.397185,"marketCap":3199816},{"date":"2024-12-27","current":-0.16471,"twenty":-3.380374,"median":-0.611466,"eighty":-0.396832,"marketCap":4396269},{"date":"2025-01-03","current":-0.172007,"twenty":-3.380374,"median":-0.611466,"eighty":-0.394932,"marketCap":4591040},{"date":"2025-01-10","current":-0.153243,"twenty":-3.381087,"median":-0.612657,"eighty":-0.392417,"marketCap":4090200},{"date":"2025-01-17","current":-0.149073,"twenty":-3.381087,"median":-0.612657,"eighty":-0.390751,"marketCap":3978902},{"date":"2025-01-24","current":-0.142818,"twenty":-3.381087,"median":-0.612657,"eighty":-0.389803,"marketCap":3811955},{"date":"2025-01-31","current":-0.133436,"twenty":-3.381087,"median":-0.612657,"eighty":-0.385763,"marketCap":3561534},{"date":"2025-02-07","current":-0.154285,"twenty":-3.381087,"median":-0.60887,"eighty":-0.382418,"marketCap":4118024},{"date":"2025-02-14","current":-0.179304,"twenty":-3.381087,"median":-0.607721,"eighty":-0.379483,"marketCap":4785812},{"date":"2025-02-21","current":-0.167837,"twenty":-3.381087,"median":-0.607721,"eighty":-0.376607,"marketCap":4479742},{"date":"2025-02-28","current":-0.145945,"twenty":-3.381087,"median":-0.607721,"eighty":-0.374146,"marketCap":3895428},{"date":"2025-03-07","current":-0.146988,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373785,"marketCap":3923253},{"date":"2025-03-14","current":-0.120396,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3088518},{"date":"2025-03-21","current":-0.130158,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3338938},{"date":"2025-03-28","current":-0.131242,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3366763},{"date":"2025-04-04","current":-0.127989,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3283289},{"date":"2025-04-11","current":-0.126904,"twenty":-3.381087,"median":-0.607721,"eighty":-0.3724,"marketCap":3255465},{"date":"2025-04-17","current":-0.143195,"twenty":-3.381087,"median":-0.607721,"eighty":-0.370776,"marketCap":3673389},{"date":"2025-04-25","current":-0.153272,"twenty":-3.3818,"median":-0.608308,"eighty":-0.370706,"marketCap":3931878},{"date":"2025-05-02","current":-0.151851,"twenty":-3.3818,"median":-0.608308,"eighty":-0.366293,"marketCap":3895428},{"date":"2025-05-09","current":-0.069765,"twenty":-3.3818,"median":-0.608308,"eighty":-0.363401,"marketCap":1789671},{"date":"2025-05-16","current":-0.104097,"twenty":-3.3818,"median":-0.608308,"eighty":-0.357147,"marketCap":2582859},{"date":"2025-05-23","current":-0.089207,"twenty":-3.3818,"median":-0.608308,"eighty":-0.345815,"marketCap":2213401},{"date":"2025-05-30","current":-0.086956,"twenty":-3.3818,"median":-0.608308,"eighty":-0.336471,"marketCap":2157553},{"date":"2025-06-06","current":-0.155412,"twenty":-3.3818,"median":-0.608308,"eighty":-0.328428,"marketCap":3856071},{"date":"2025-06-13","current":-0.164848,"twenty":-3.3818,"median":-0.608308,"eighty":-0.307874,"marketCap":4090219},{"date":"2025-06-20","current":-0.148812,"twenty":-3.382513,"median":-0.607721,"eighty":-0.253225,"marketCap":3692332},{"date":"2025-06-27","current":-0.145249,"twenty":-3.382513,"median":-0.601576,"eighty":-0.23981,"marketCap":3603912},{"date":"2025-07-03","current":-0.161746,"twenty":-3.382513,"median":-0.592593,"eighty":-0.23598,"marketCap":4013243},{"date":"2025-07-11","current":-0.171641,"twenty":-3.382513,"median":-0.57922,"eighty":-0.227685,"marketCap":4258749},{"date":"2025-07-18","current":-0.17416,"twenty":-3.382513,"median":-0.575195,"eighty":-0.221331,"marketCap":4321253},{"date":"2025-07-25","current":-0.18033,"twenty":-3.382513,"median":-0.567502,"eighty":-0.218282,"marketCap":4474354},{"date":"2025-08-01","current":-0.162914,"twenty":-3.382513,"median":-0.563857,"eighty":-0.21025,"marketCap":4042229},{"date":"2025-08-08","current":-0.142395,"twenty":-3.382513,"median":-0.559832,"eighty":-0.201865,"marketCap":3533100},{"date":"2025-08-15","current":-0.141271,"twenty":-3.382513,"median":-0.552295,"eighty":-0.197588,"marketCap":4175109},{"date":"2025-08-22","current":-0.139484,"twenty":-3.382513,"median":-0.546449,"eighty":-0.189036,"marketCap":4122320},{"date":"2025-08-29","current":-0.134386,"twenty":-3.382513,"median":-0.540844,"eighty":-0.185506,"marketCap":3971632},{"date":"2025-09-05","current":-0.126721,"twenty":-3.383226,"median":-0.539113,"eighty":-0.183327,"marketCap":3745120},{"date":"2025-09-12","current":-0.136594,"twenty":-3.382513,"median":-0.536517,"eighty":-0.180793,"marketCap":4036898},{"date":"2025-09-19","current":-0.134158,"twenty":-3.382513,"median":-0.534056,"eighty":-0.178011,"marketCap":3964913},{"date":"2025-09-26","current":-0.126526,"twenty":-3.382513,"median":-0.53303,"eighty":-0.175763,"marketCap":3739362},{"date":"2025-10-03","current":-0.131852,"twenty":-3.382513,"median":-0.53227,"eighty":-0.172728,"marketCap":3896768},{"date":"2025-10-10","current":-0.15897,"twenty":-3.382513,"median":-0.53227,"eighty":-0.171412,"marketCap":4698197},{"date":"2025-10-17","current":-0.140004,"twenty":-3.382513,"median":-0.53227,"eighty":-0.170011,"marketCap":4137677},{"date":"2025-10-24","current":-0.111068,"twenty":-3.382513,"median":-0.53227,"eighty":-0.166945,"marketCap":3282499},{"date":"2025-10-31","current":-0.105222,"twenty":-3.382513,"median":-0.53227,"eighty":-0.163465,"marketCap":3109736},{"date":"2025-11-07","current":-0.088757,"twenty":-3.382513,"median":-0.53227,"eighty":-0.161746,"marketCap":2623120},{"date":"2025-11-14","current":-0.313947,"twenty":-3.382513,"median":-0.531784,"eighty":-0.161746,"marketCap":9278401},{"date":"2025-11-21","current":-0.276075,"twenty":-3.382513,"median":-0.52958,"eighty":-0.161746,"marketCap":7230405},{"date":"2025-11-28","current":-0.347703,"twenty":-3.382513,"median":-0.526633,"eighty":-0.161746,"marketCap":9106329},{"date":"2025-12-05","current":-0.311245,"twenty":-3.382513,"median":-0.522447,"eighty":-0.161746,"marketCap":8151497},{"date":"2025-12-12","current":-0.29965,"twenty":-3.382513,"median":-0.518527,"eighty":-0.161746,"marketCap":7847840},{"date":"2025-12-19","current":-0.225575,"twenty":-3.382513,"median":-0.514773,"eighty":-0.161746,"marketCap":5907811},{"date":"2025-12-26","current":-0.250696,"twenty":-3.382513,"median":-0.51073,"eighty":-0.161746,"marketCap":6565734},{"date":"2026-01-02","current":-0.271051,"twenty":-3.382513,"median":-0.509351,"eighty":-0.161746,"marketCap":7098820},{"date":"2026-01-09","current":-0.282645,"twenty":-3.382513,"median":-0.506297,"eighty":-0.161746,"marketCap":7402477},{"date":"2026-01-16","current":-0.282117,"twenty":-3.382513,"median":-0.503101,"eighty":-0.161746,"marketCap":7388656},{"date":"2026-01-23","current":-0.281709,"twenty":-3.382513,"median":-0.502006,"eighty":-0.161746,"marketCap":7377958},{"date":"2026-01-30","current":-0.253933,"twenty":-3.334273,"median":-0.494301,"eighty":-0.161746,"marketCap":6650504},{"date":"2026-02-06","current":-0.272178,"twenty":-3.252764,"median":-0.492695,"eighty":-0.161746,"marketCap":7128342},{"date":"2026-02-13","current":-0.245763,"twenty":-3.208088,"median":-0.491105,"eighty":-0.161746,"marketCap":6436546},{"date":"2026-02-20","current":-0.267821,"twenty":-3.135609,"median":-0.486305,"eighty":-0.161746,"marketCap":7014231},{"date":"2026-02-27","current":-0.268229,"twenty":-3.106609,"median":-0.484264,"eighty":-0.161746,"marketCap":7024929},{"date":"2026-03-06","current":-0.251074,"twenty":-3.065031,"median":-0.475167,"eighty":-0.161746,"marketCap":6575619},{"date":"2026-03-13","current":-0.349693,"twenty":-2.974254,"median":-0.470717,"eighty":-0.161746,"marketCap":8301358},{"date":"2026-03-20","current":-0.358805,"twenty":-2.93252,"median":-0.461346,"eighty":-0.161746,"marketCap":8517679},{"date":"2026-03-27","current":-0.432654,"twenty":-2.899148,"median":-0.457248,"eighty":-0.161746,"marketCap":10270779},{"date":"2026-04-02","current":-0.438067,"twenty":-2.887322,"median":-0.45206,"eighty":-0.161746,"marketCap":10399278},{"date":"2026-04-10","current":-0.497224,"twenty":-2.851634,"median":-0.450737,"eighty":-0.161746,"marketCap":11803594},{"date":"2026-04-17","current":-0.487751,"twenty":-2.82692,"median":-0.450143,"eighty":-0.161746,"marketCap":11578720},{"date":"2026-04-24","current":-0.736556,"twenty":-2.772306,"median":-0.450143,"eighty":-0.161746,"marketCap":17485106},{"date":"2026-05-01","current":-0.693252,"twenty":-2.734252,"median":-0.450143,"eighty":-0.161746,"marketCap":16457110},{"date":"2026-05-08","current":-0.769904,"twenty":-2.706558,"median":-0.450143,"eighty":-0.161746,"marketCap":16521360},{"date":"2026-05-15","current":-0.686497,"twenty":-2.646368,"median":-0.450143,"eighty":-0.161746,"marketCap":14731546},{"date":"2026-05-22","current":-0.634315,"twenty":-2.392511,"median":-0.450143,"eighty":-0.161746,"marketCap":13611765},{"date":"2026-05-29","current":-0.660834,"twenty":-2.280143,"median":-0.450143,"eighty":-0.161746,"marketCap":14180834},{"date":"2026-06-05","current":-0.60416,"twenty":-2.258363,"median":-0.450143,"eighty":-0.161746,"marketCap":12964678},{"date":"2026-06-12","current":-0.656557,"twenty":-2.206982,"median":-0.450143,"eighty":-0.161746,"marketCap":14089049},{"date":"2026-06-18","current":-0.577428,"twenty":-2.17461,"median":-0.450143,"eighty":-0.161746,"marketCap":12391020},{"date":"2026-06-26","current":-0.51113,"twenty":-2.11719,"median":-0.450143,"eighty":-0.161746,"marketCap":10968347},{"date":"2026-07-02","current":-0.535938,"twenty":-2.082937,"median":-0.450143,"eighty":-0.161746,"marketCap":11500702},{"date":"2026-07-10","current":-0.501507,"twenty":-1.979978,"median":-0.450143,"eighty":-0.161746,"marketCap":10761830},{"date":"2026-07-17","current":-0.488461,"twenty":-1.909689,"median":-0.450143,"eighty":-0.161746,"marketCap":10481885},{"date":"2026-07-24","current":-0.464081,"twenty":-1.679615,"median":-0.450143,"eighty":-0.161746,"marketCap":9958708},{"date":"2026-07-31","current":-0.449324,"twenty":-1.554283,"median":-0.448858,"eighty":-0.161746,"marketCap":9642049},{"date":"2026-08-07","current":-0.480762,"twenty":-1.435484,"median":-0.448751,"eighty":-0.161746,"marketCap":10316671},{"date":"2026-08-14","current":-0.908531,"twenty":-1.395884,"median":-0.448751,"eighty":-0.161746,"marketCap":10555313},{"date":"2026-08-21","current":-0.909321,"twenty":-1.363639,"median":-0.448751,"eighty":-0.161746,"marketCap":10564492}],"updateTime":1787576358366},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TOVX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633924436","title":"Theriva Biologics Q1 EPS $(0.05), Inline","url":"https://stock-news.laohu8.com/highlight/detail?id=2633924436","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633924436?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:47","pubTimestamp":1778014025,"startTime":"0","endTime":"0","summary":"Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 96.77 percent increase over losses of $(1.55) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52306057/theriva-biologics-q1-eps-0-05-inline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Theriva Biologics Q1 EPS $(0.05), Inline","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633921476","title":"Press Release: Theriva(TM) Biologics Reports First Quarter 2026 Operational Highlights and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633921476","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633921476?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:30","pubTimestamp":1778013000,"startTime":"0","endTime":"0","summary":"-- Alignment with the FDA on the Phase 3 trial design of VCN-01  for treatment of metastatic pancreatic ductal adenocarcinoma  --. -- Additional data from VIRAGE Phase 2b clinical trial of VCN-01 in metastatic PDAC patients presented at the recent AACR Annual Meeting may reflect an immune-mediated mechanism of action and demonstrate improved outcomes in VCN-01 treated patients across multiple subgroups, including patients with liver metastases --. -- VCN-01 administered to retinoblastoma patients under a compassionate use program, which is expected to provide dosing feasibility and tolerability data for a potential Phase 2/3 clinical trial --. -- Cash and cash equivalents of $14.4 million as of March 31, 2026; cash runway into Q1 2027 --. ROCKVILLE, Md., May 05, 2026  -- Theriva Biologics, Inc. , a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial results for the first quarter e","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4099","TM","03160","TOVX","BK4195","BK4139","PFS","BK4555","BK4585","BK4604","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628740330","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2628740330","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628740330?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:53","pubTimestamp":1776685986,"startTime":"0","endTime":"0","summary":"Theriva Biologics (TOVX) shares were up 94% in Monday premarket activity, adding to Friday's gain.Compass Pathways (CMPS) stock was 25% higher after the company said over the weekend it commended the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","LU2065169927.USD","LU2023250504.SGD","LU0417517546.SGD","BK7044","LU0426417589.USD","LU1852331112.SGD","IE00BHPRN162.USD","LU0308772762.SGD","IE00BMPRXR70.SGD","LU1084165304.USD","LU2272731865.HKD","LU0965509283.SGD","LU0251142724.SGD","LU1934455863.HKD","LU1145028129.USD","LU0426412945.USD","LU1496350171.SGD","LU2065171402.SGD","BK4573","LU2237443465.HKD","LU0342679015.USD","LU1069347547.HKD","IE00BQXX3D17.EUR","LU0345768740.USD","LU2357627491.SGD","LU1670756490.USD","LU2463028550.USD","IE00B5949003.HKD","BK4598","LU1917777945.USD","IE0004086264.USD","LU2362540622.SGD","LU0444971666.USD","LU2720916845.USD","LU1989764748.USD","LU0345770993.USD","LU1035775433.USD","LU0133085943.USD","HK0000532082.HKD","LU0234572021.USD","LU2250418816.HKD","LU0256863811.USD","LU0528227936.USD","IE00BQXX3C00.GBP","LU0345769128.USD","LU2089985449.USD","LU0642271901.SGD","LU2471134879.HKD","LU0203347892.USD","LU0312595415.SGD","LU0289960550.SGD","LU1861220033.SGD","LU2360032135.SGD","LU0302445910.USD","LU0889566641.SGD","LU2063271972.USD","LU0070302665.USD","LU1153585028.USD","LU1923622614.USD","IE00BDRTCR15.USD","LU1803068979.SGD","LU2097344357.USD","LU0345770308.USD","BK4587","LU2746668974.SGD","LU1046421795.USD","LU2403377893.USD","LU0130103400.USD","LU0689626769.HKD","LU0107464264.USD","LU2357305700.SGD","LU1935043023.USD","LU0348723411.USD","LU0661504455.SGD","IE0002270589.USD","LU1430594728.SGD","LU1674673428.USD","LU1992135399.USD","LU0553294199.USD","LU0976567544.SGD","LU1868837300.USD","LU1232071149.USD","LU2471134952.CNY","LU1585245621.USD","LU0106261372.USD","LU1989764664.SGD","LU2077746001.SGD","LU0094547139.USD","LU0320765059.SGD","LU0048573561.USD","LU0079474960.USD","LU0080751232.USD","LU2023250843.SGD","LU1815333072.USD","SG9999014880.SGD","IE00BYXW3230.USD","LU2430703178.SGD","LU2471134796.USD","LU0096364046.USD","LU1032955483.USD","LU1035773651.USD","LU0210536198.USD","LU1119994496.HKD","IE00BJLML261.HKD","LU0128525689.USD","LU2111349929.HKD","SG9999015978.USD","LU0965508806.USD","HK0000304805.HKD","LU0234570918.USD","LU1571399168.USD","LU2236285917.USD","LU2954938101.SGD","IE00B775H168.HKD","IE00B7SZLL34.SGD","LU2286300806.USD","BK4503","LU0069063385.USD","LU0949170426.SGD","BK4548","LU2272731600.USD","LU0127658192.USD","LU2265009873.SGD","LU0742534661.SGD","LU1316542783.SGD","LU2168564222.USD","LU1366333091.USD","LU1951200564.SGD","BK4077","LU0859254822.USD","LU0345774631.USD","LU1127390331.HKD","LU1989772840.SGD","LU1496350502.SGD","SG9999018865.SGD","LU0788109477.HKD","LU1074936037.SGD","LU0456855351.SGD","LU0823434583.USD","LU0082616367.USD","LU1935042215.USD","GB00B4LPDJ14.GBP","LU0345768153.USD","LU1868836591.USD","LU1989772923.USD","BK4104","BK4566","IE0000B7K699.USD","LU1803068623.USD","LU0130102774.USD","LU2420271590.USD","LU1923623000.USD","LU0109392836.USD","SG9999014914.USD","BK4602","IE000F7OJYX1.SGD","IE00B19Z8X17.USD","LU2326559502.SGD","USJW.SI","LU0077335932.USD","MRVU","LU0124676726.USD","IE000BZT7R73.USD","LU0096362180.USD","GGLL","LU2089284900.SGD","BK4579","LU0690374961.EUR","LU1121112475.USD","LU2271345857.HKD","BK4201","BK4576","BK4514","LU2750360641.GBP","LU0433182093.SGD","IE00BFSS8Q28.SGD","LU1037948541.HKD","LU1935043536.SGD","LU0267386448.USD","SG9999015952.SGD","LU0174119429.USD","LU0198837287.USD","IE00BFMHRM44.USD","LU0310800379.SGD","LU0476273544.USD","LU0130518102.USD","LU1069344957.HKD","LU0708995401.HKD","LU0477156797.USD","LU2360107168.USD","LU1791710400.SGD","BK4553","LU2860962120.EUR","LU0323591593.USD","LU2023251221.USD","LU1169590202.USD","LU0444973449.USD","LU0143551892.USD","LU0545039389.USD","LU2543165471.USD","LU1489326972.SGD","LU0942090050.USD","LU0203201768.USD","MRVL","BK4585","LU0175139822.USD","IE00BZ1G4Q59.USD","LU2237438978.USD","LU1823568750.SGD","LU0170899867.USD","IE00B19Z8W00.USD","LU2999663052.SGD","LU2191332357.HKD","LU2125154778.USD","LU0878866978.SGD","IE00BQXX3F31.USD","IE00BN8TJ469.HKD","LU0353189680.USD","LU1267930573.SGD","IE00B3S45H60.SGD","SGXZ99366536.SGD","LU1868836757.USD","LU0130517989.USD","BK4525","IE00BMPRXN33.USD","LU0820562030.AUD","IE00BSNM7G36.USD","LU2087625088.SGD","LU0203345920.USD","IE00B7KXQ091.USD","LU0683600562.USD","LU0251131958.USD","LU2106854487.HKD","LU0061475181.USD","LU2462591277.SGD","LU2931357623.SGD","GOOG","LU2746668461.USD","LU0823434740.USD","LU1244550221.USD","BK4507","LU1814569148.SGD","LU2092937148.SGD","LU1201861249.SGD","LU2065170008.USD","LU1066051498.USD","LU0276348264.USD","LU0889565833.HKD","LU1201861165.SGD","LU1066051225.USD","LU2552382132.HKD","LU0472753341.HKD","IE0034235295.USD","GOU","LU2237443622.USD","IE0004445239.USD","IE0004445015.USD","LU1235294995.USD","BK4604","LU1548497426.USD","LU0211327993.USD","LU1699723380.USD","BK4561","LU0792757196.USD","LU1868836914.USD","LU2108987350.USD","LU2360106780.USD","LU2430703095.HKD","GB00B4QBRK32.GBP","LU1633808545.USD","LU0158827781.USD","GOOX","LU0787776722.HKD","LU0943347566.SGD","LU2362541513.USD","IE0001KFT4U8.USD","LU1868837136.USD","IE0034235303.USD","LU0786609619.USD","LU2491050154.USD","LU2211815571.USD","LU2381873111.SGD","BK4543","LU0345774391.USD","LU0070217475.USD","LU1280957306.USD","LU2456880835.USD","LU1839511570.USD","IE00BBT3K403.USD","LU2087621335.USD","LU2505996509.AUD","LU1934455277.USD","LU2168564149.EUR","LU0820561909.HKD","LU0354030438.USD","LU0466842654.USD","LU2491050071.SGD","LU2089283258.USD","LU2491049909.HKD","LU2552382058.USD","LU2275660780.HKD","LU1894683348.USD","LU2247934214.USD","HK0000819398.USD","LU1670628061.USD","LU2764263203.CNY","LU0784383803.USD","LU0238689110.USD","BK4574","IE0009356076.USD","LU0289961442.SGD","LU0640476718.USD","SG9999002232.USD","IE00BFSS7M15.SGD","IE00B1BXHZ80.USD","LU0784385170.HKD","LU1645745479.HKD","LU1629891620.HKD","IE00BKPKM429.USD","LU0316494557.USD","LU0256863902.USD","LU2028103732.USD","LU1935042991.SGD","LU0187121727.USD","LU2242649171.HKD","LU2362541273.HKD","LU0072462426.USD","LU2125154935.USD","IE00BYQQ9H92.USD","BK4612","CMPS","LU1861215975.USD","LU1974910355.USD","LU2756315664.SGD","LU2764262908.HKD","LU0985489474.SGD","LU1791710582.SGD","LU0820561818.USD","IE0034235188.USD","LU0138981039.USD","LU0964807845.USD","LU1202635105.USD","LU0310799852.SGD","LU2361044949.HKD","BK4097","IE00BLSP4239.USD","LU2097829019.USD","LU2361044865.SGD","LU0210528500.USD","LU2097344431.USD","BK4588","SG9999002224.SGD","IE00BMPRXQ63.HKD","LU0057025933.USD","LU2473716301.USD","LU1116320901.HKD","LU0477156953.USD","LU2264538146.SGD","LU0823421416.USD","LU1674673691.USD","LU2290526834.HKD","LU0011850046.USD","QXO","LU0648001328.SGD","LU2054465674.USD","LU0157215616.USD","LU1435385759.SGD","LU2237443895.HKD","LU0861579265.USD","LU1066051811.HKD","LU1670627923.USD","LU1301847155.USD","LU1267930813.SGD","LU0208291251.USD","IE000WAW04H5.SGD","LU0965509010.AUD","LU0994945656.USD","IE00BKVL7J92.USD","LU2322448791.USD","LU2065171311.SGD","LU0289941410.SGD","E","LU0719512351.SGD","LU1221951129.SGD","LU2242650005.HKD","BK4534","LU0210533765.USD","LU1429558221.USD","LU1400636491.USD","LU1951198990.SGD","LU1720051108.HKD","LU2458330169.SGD","LU0738911758.USD","LU1267930730.SGD","LU0690374615.EUR","LU0882574139.USD","BK4581","LU0006306889.USD","LU0211326839.USD","LU0211326755.USD","LU0265550359.USD","LU1196500208.SGD","BK4141","BK4527","LU2322448957.HKD","LU2461242641.AUD","SG9999000418.SGD","LU0097036916.USD","LU0957791311.USD","LU0061474960.USD","LU2487616109.SGD","LU0314106906.USD","LU2750360997.AUD","SG9999017495.SGD","LU1804176565.USD","LU1551013342.USD","BLD","LU0052756011.USD","LU2404859741.USD","LU1116320737.USD","BK4554","LU0048584097.USD","LU2168563687.JPY","LU1988902786.USD","IE00BK4W5M84.HKD","LU0061474705.USD","LU2237443549.SGD","LU1244550577.SGD","LU2602419157.SGD","LU0494093205.USD","GOOW","LU0068578508.USD","LU1551013425.SGD","BK4592","LU0211328371.USD","LU0310800965.SGD","LU1169589451.USD","IE00BDCRKT87.USD","LU2896262040.SGD","LU1934455194.USD","LU0784385840.USD","BK4550","LU0868494708.USD","LU0320765489.SGD","LU1691799644.USD","SG9999015986.USD","TOVX","BK4605","LU2092627202.USD","LU0128525929.USD","LU2237443978.SGD","IE00BJTD4V19.USD","GGLS","LU1267930227.SGD","LU0274383776.USD","LU2244417387.USD","SGXZ31699556.SGD","LU0965509101.SGD","IE00BFXG0V08.USD","LU2272731782.SGD","IE000MB6IJN5.SGD","LU1880398554.USD","BK4139","LU1642822529.SGD","LU0029864427.USD","SG9999018857.SGD","LU0980610538.SGD","BK4533","LU0149725797.USD","MVLL","LU2237443382.USD","IE00B19Z3B42.SGD","BK4532","BK4515","SG9999014906.USD","IE000SO60NU8.SGD","LU0053666078.USD","IE00BWXC8680.SGD","LU0949170772.SGD","LU0203202063.USD","LU0985320562.USD","LU2756315318.SGD","LU2592432038.USD","IE000M9KFDE8.USD","LU0056508442.USD","LU2023250330.USD","LU1778281490.HKD","LU0868494617.USD","SGXZ51526630.SGD","LU1066053197.SGD","IE00BJTD4N35.SGD","LU1221951046.USD","IE00BJJMRY28.SGD","IE00B5TLWC47.USD","LU0081259029.USD","IE0005OL40V9.USD","SG9999001077.SGD","LU0354030511.USD","LU1894683264.USD","LU1261432733.SGD","IE00BK4W5L77.USD","LU2433249047.HKD","LU1815336760.USD","GOOY","SG9999014898.SGD","HK0000304797.USD","LU2125909593.SGD","LU1043141123.HKD","LU1880398471.USD","IE00B19Z9505.USD","LU2505996681.GBP","LU0251132253.USD","SGXZ81514606.USD","LU2764263039.SGD","LU1003077747.HKD","BK4538","LU2098885051.SGD","LU0211331839.USD","LU2462157665.USD","LU2125909247.SGD","BK4088","IE00BKDWB100.SGD","LU2213496289.HKD","LU2168564495.EUR","LU0353189763.USD","LU1400636574.HKD","LU1323610961.USD","LU0225283273.USD","GOOGL","SG9999015945.SGD","IE00BJJMRX11.SGD","LU1718418525.SGD","LU1064131342.USD","LU0648000940.SGD","LU1400636657.SGD","LU2458330243.SGD","LU2430703251.USD","LU2168564065.EUR","LU1506573853.SGD","IE00B4JS1V06.HKD","IE00BZ199S13.USD","LU0557290698.USD","LU1992135472.HKD","LU1043141396.HKD","LU0345769631.USD","LU0724617625.USD","LU0689472784.USD","LU1059921491.USD","LU1366192091.USD","IE00BLSP4452.SGD","LU0215105999.USD","LU1935042488.USD","LU2404859667.USD","LU0511384066.AUD","LU2417539215.USD","LU0823421333.USD","LU0109391861.USD","LU0265550946.USD","LU2361045086.USD","IE00BN29S564.USD","LU0672654240.SGD","IE00B775SV38.USD","LU0784384876.USD","LU1244550494.USD","LU1303367103.USD","IE00B1XK9C88.USD","LU2471134523.USD","LU0289739343.SGD","LU0708994859.HKD","LU1720051017.SGD","LU1037948897.HKD","IE00B19Z3581.USD","LU1914381329.SGD","LU0158827948.USD","LU2462591350.SGD","GOOP","LU1267930490.SGD","IE0004091025.USD","LU0496365809.HKD","LU2552382215.SGD","LU0314104364.USD","LU0957808578.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628784874","title":"Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628784874","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628784874?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:11","pubTimestamp":1776456712,"startTime":"0","endTime":"0","summary":"Theriva Biologics (TOVX) “announced an upcoming poster presentation of new data and subgroup analyses from the VIRAGE Phase 2b clinical trial evalu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-to-present-additional-data-on-phase-2b-vcn-01clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-to-present-additional-data-on-phase-2b-vcn-01clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628781423","title":"Theriva to present new VIRAGE Phase 2b VCN-01 data in metastatic pancreatic cancer at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2628781423","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628781423?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:05","pubTimestamp":1776456333,"startTime":"0","endTime":"0","summary":"Theriva Biologics set an April 20, 2026 poster at AACR 2026 to present additional tumor-response, biomarker, and subgroup data from VIRAGE, its Phase 2b trial of VCN-01 with gemcitabine and nab-paclitaxel in newly diagnosed metastatic pancreatic cancer.Planned analyses are expected to reinforce an immune-mediated mechanism for VCN-01, with improved outcomes reported across multiple patient subgroups, including patients with liver metastases.Management highlighted prior VIRAGE observations showing longer-lasting responses with VCN-01, with survival benefit emerging later versus chemotherapy alone.Theriva reported alignment with FDA and EMA on a proposed pivotal Phase 3 trial evaluating multiple VCN-01 doses with gemcitabine and nab-paclitaxel in first-line metastatic pancreatic cancer.Company also plans a small dosing study to test whether more frequent and extended VCN-01 administration can further improve outcomes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL2GGKTq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","TOVX","SG9999014013.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628495781","title":"Theriva™ Biologics Announces Upcoming Presentation of Additional Data From the Virage Phase 2B Clinical Trial of Vcn-01 in Metastatic Pancreatic Cancer at Aacr 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628495781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628495781?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:05","pubTimestamp":1776456300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nTUA8VWW5K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626158173","title":"Theriva Biologics Faces Delays in Warrant Approval Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2626158173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626158173?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:52","pubTimestamp":1775767971,"startTime":"0","endTime":"0","summary":"An update from Theriva Biologics ( ($TOVX) ) is now available. On April 9, 2026, Theriva Biologics was unable to convene a Special Meeting of Stock...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-faces-delays-in-warrant-approval-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-faces-delays-in-warrant-approval-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624553303","title":"Theriva Biologics Raised to Buy From Hold by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2624553303","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624553303?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:07","pubTimestamp":1774991220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TOVX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2026 17:07 ET (21:07 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623877055","title":"Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path","url":"https://stock-news.laohu8.com/highlight/detail?id=2623877055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623877055?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:48","pubTimestamp":1774964920,"startTime":"0","endTime":"0","summary":"As previously reported, Maxim Jason McCarthy upgraded Theriva Biologics (TOVX) to Buy from Hold with a $1 price target The firm says the the path f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-upgraded-to-buy-at-maxim-on-clearer-vcn-01-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-upgraded-to-buy-at-maxim-on-clearer-vcn-01-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621098837","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Apogee Therapeutics (APGE) and Theriva Biologics (TOVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621098837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621098837?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:30","pubTimestamp":1774359006,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Theriva Biologics (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-apogee-therapeutics-apge-and-theriva-biologics-tovx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-apogee-therapeutics-apge-and-theriva-biologics-tovx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","HCSG","XBI","BK4137","BK4581","LU0053671581.USD","TOVX","XLV","APGE","BK4139","LABU","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621370544","title":"Theriva Biologics Advances VCN-01 Into Pivotal Phase 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2621370544","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621370544?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:27","pubTimestamp":1774268833,"startTime":"0","endTime":"0","summary":"An announcement from Theriva Biologics ( ($TOVX) ) is now available. On March 23, 2026, Theriva Biologics reported that a recent Type B End-of-Phas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-advances-vcn-01-into-pivotal-phase-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/theriva-biologics-advances-vcn-01-into-pivotal-phase-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621708016","title":"Theriva Biologics reports FDA agreement on Phase 3 VCN-01 trial design in metastatic pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2621708016","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621708016?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:02","pubTimestamp":1774267332,"startTime":"0","endTime":"0","summary":"Theriva reported that the FDA generally agreed with the proposed design for a Phase 3 trial of VCN-01 plus gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel plus placebo as first-line treatment for metastatic pancreatic ductal adenocarcinoma.The planned Phase 3 study is described as randomized and double-blinded, with overall survival as the primary endpoint and progression-free survival among the key secondary endpoints.The FDA agreed with repeat dosing in “macrocycles” and the use of an adaptive design, including interim analyses and potential sample size re-estimation criteria.Theriva said Phase 2 VIRAGE results were already presented in 2025, reporting improvements in overall survival, progression-free survival, and duration of response versus standard-of-care chemotherapy alone.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL9z3F5t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","TOVX","BK4112","NDAQ","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","BK4585","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621870827","title":"Theriva™ Biologics Announces Positive End-of-Phase 2 Meeting With U.S. FDA Regarding the Design of a Phase 3 Trial of Vcn-01 in Metastatic Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2621870827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621870827?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:00","pubTimestamp":1774267211,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0HE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619900741","title":"Theriva Biologics price target lowered to $4 from $7 at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2619900741","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619900741?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:38","pubTimestamp":1773409136,"startTime":"0","endTime":"0","summary":"Alliance Global lowered the firm’s price target on Theriva Biologics (TOVX) to $4 from $7 and keeps a Buy rating on the shares following the Q4 rep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-price-target-lowered-to-4-from-7-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-price-target-lowered-to-4-from-7-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618134210","title":"Theriva Biologics Q4 EPS $(0.12) Beats $(0.50) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618134210","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618134210?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:35","pubTimestamp":1773318934,"startTime":"0","endTime":"0","summary":"Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.50) by 76.2 percent. This is a 92.52 percent increase over losses of $(1.59) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51210044/theriva-biologics-q4-eps-0-12-beats-0-50-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618131733","title":"Press Release: Theriva(TM) Biologics Reports Full-Year 2025 Operational Highlights and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131733","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131733?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:01","pubTimestamp":1773316860,"startTime":"0","endTime":"0","summary":"- Licensed SYN-020 to Rasayana Therapeutics for development in multiple indications; up to $38 million in potential milestones plus royalties on commercial sales -. - Cash and cash equivalents of $13.1 million as of December 31, 2025; recent capital raises increase cash to $15.2 million as of February 26, 2026 and provides cash runway into Q1 2027-. ROCKVILLE, M.D., March 12, 2026  -- Theriva Biologics, Inc. , a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial results for the full year ended December 31, 2025, and provided a corporate update.-- As recently announced, Theriva received positive scientific advice from. the EMA on the design of a Phase 3 trial in PDAC. The EMA provided. overall agreement with the proposed Phase 3 clinical trial of VCN-01 in. of metastatic PDAC, including sample size, repeated dosing of VCN-01, and. an adaptive design to potentially optimize trial t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4139","BK4588","BK4099","TM","TOVX","BK4585","03160","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618131420","title":"Theriva Biologics FY2025 net loss attributable to common stockholders was USD 25.25 million and G&A expenses more than doubled to USD 15.45 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618131420","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618131420?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316841,"startTime":"0","endTime":"0","summary":"Theriva Biologics FY2025 net loss attributable to common stockholders was USD 25.25 million and G&A expenses more than doubled to USD 15.45 million. Theriva reported a FY 2025 net loss of USD 23.74 million, compared with a 7% narrower net loss attributable to common stockholders of USD 25.25 million. FY 2025 general and administrative expenses rose to USD 15.45 million, more than doubled, primarily due to a USD 9 million contingent consideration adjustment tied to the VIRAGE Phase 2b trial of VCN-01 in PDAC achieving its primary survival and safety endpoints. FY 2025 research and development expenses fell 28% to USD 8.6 million, mainly reflecting lower clinical trial costs following completion of the VIRAGE Phase 2b study and lower SYN-004 trial spending, partly offset by higher SYN-020 patent expenses. Cash and cash equivalents were USD 13.06 million at year-end 2025, and management said recent capital raises lifted cash to about USD 15.2 million as of February 26, 2026, providing run","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL56nxtG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","LU2210150020.SGD","NDAQ","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","TOVX","SG9999014005.SGD","LU0314104364.USD","LU2095319765.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618317981","title":"Theriva Biologics Inc: Anticipates Research & Development Expense to Decrease in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618317981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618317981?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316807,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUADT2T0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614663758","title":"Alliance Global Partners Sticks to Its Buy Rating for Theriva Biologics (TOVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614663758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614663758?lang=en_us&edition=fundamental","pubTime":"2026-02-28 01:25","pubTimestamp":1772213152,"startTime":"0","endTime":"0","summary":"In a report released yesterday, James Molloy from Alliance Global Partners maintained a Buy rating on Theriva Biologics, with a price target of $7....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-sticks-to-its-buy-rating-for-theriva-biologics-tovx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alliance-global-partners-sticks-to-its-buy-rating-for-theriva-biologics-tovx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612449137","title":"BRIEF-Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2612449137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612449137?lang=en_us&edition=fundamental","pubTime":"2026-02-18 22:02","pubTimestamp":1771423355,"startTime":"0","endTime":"0","summary":"BRIEF-Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple IndicationsFeb 18 (Reuters) - Theriva Biologics Inc TOVX.A:THERIVA BIOLOGICS LICENSES SYN-020 TO RASAYANA THERAPEUTICS FO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZE02I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":44,"code":"91000000","status":"200"}]}}